ADA and inflammatory bowel disease: For example, van Schouwenburg et al. described a transient ADA response in 17/53 ADA-positive RA patients treated with adalimumab (22), while Steenholdt et al. described transient detection of ADA in inflammatory bowel disease (IBD) patients treated with infliximab (57).